Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine

NCT01702337 · clinicaltrials.gov ↗

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Papillomavirus Infection

Interventions

OTHER: Prevalence-based model

Sponsor

GlaxoSmithKline